PR Newswire
NEW YORK, Sept. 21, 2016
NEW YORK, Sept. 21, 2016 /PRNewswire/ -- Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company")(NASDAQ: SPPI) arising from possible breaches of fiduciary duty by certain of its officers and directors in connection with the Company's pursuit of Food and Drug Administration approval of its proposed bladder cancer drug apaziquone.
Click here for more information about our investigation of SPPI: http://hkh-lawfirm.com/investigations-cases/spectrum-pharmaceuticals-inc-sppi/
Hynes Keller & Hernandez, LLC is a national law firm that represents institutional and individual investors. The firm is focused on providing exemplary legal services in the area of shareholder litigation. The firm has an experienced litigation team which has achieved significant victories on behalf of the firm's clients. You can visit our website at www.hkh-lawfirm.com for more information. Attorney advertising. Prior results do not guarantee similar outcomes.
If you hold shares in SPPI and would like to obtain additional information about your legal rights and protect your investment, please visit our website or contact the attorneys below. There is no cost or obligation to you.
Contact: | |
| |
Hynes Keller & Hernandez, LLC | Hynes Keller & Hernandez, LLC |
Michael J. Hynes, Esq. | Beth A. Keller, Esq. |
1150 First Avenue, Suite 501 | 118 North Bedford Road, Suite 100 |
King of Prussia, PA 19406 | Mount Kisco, NY 10549 |
Telephone: (610) 994-0292 | Telephone: (914) 752-3040 |
Email: mhynes@hkh-lawfirm.com | Email: bkeller@hkh-lawfirm.com |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hynes-keller--hernandez-llc-announces-investigation-of-spectrum-pharmaceuticals-inc-sppi-300331550.html
SOURCE Hynes Keller & Hernandez, LLC
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.